Retraction
HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells
Paper Information
Record ID:
42490
Author(s):
Journal:
Publication Date:
December 13, 2018
Retraction Date:
May 16, 2022
(3.5 years years ago)
Subjects:
Institution:
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reason:
Nature of Retraction:
Retraction
Retraction Notice:
10.1089/hum.2017.256.retractAdditional Notes:
See also: https://pubpeer.com/publications/C80A3FCA7DACF2DEBA7797637AA362
Citations (32)
32
Total Citations5
Post-Retraction(15.6%)
27
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
1
After 2+ years
783
Days since retraction (latest)
Long non-coding RNAs; potential contributors in cancer chemoresistance through modulating diverse molecular mechanisms and signaling pathways
Hashem O. Alsaab, Mohammad S. Alzahrani, Atheer F. Alaqile et al. (5 authors)
Pathology - Research and Practice
Published: Jul 2024
783 days after retraction
<scp>LINC00460</scp> knockdown sensitizes cervical cancer to cisplatin by downregulating <scp>TGFBI</scp>
Ping Tian, Yuanyuan Feng, Ling Tao
Chemical Biology & Drug Design
Published: Dec 2023
2 citations
2 citations
591 days after retraction
The clinical significance of long noncoding RNAs expression in cervical cancers
Maryame Lamsisi, Amal Bouziyane, Berjas Abumsimir et al. (12 authors)
Elsevier eBooks
Published: Jan 2023
230 days after retraction
Significance of HOXD transcription factors family in progression, migration and angiogenesis of cancer
Lumin Wang, Chenyang Qiao, Li Cao et al. (9 authors)
Critical Reviews in Oncology/Hematology
Published: Sep 2022
15 citations
15 citations
120 days after retraction
Downregulation of <scp><i>NRARP</i></scp> exerts anti‐tumor activities in the breast tumor cells depending on Wnt/β‐catenin‐mediated signals: The role of <scp>miR</scp>‐130a‐3p
Jafar Poodineh, Majid Sirati‐Sabet, Masoumeh Rajabibazl et al. (5 authors)
Chemical Biology & Drug Design
Open Access
Published: Jul 2022
11 citations
11 citations
52 days after retraction
LncRNA HOXD-AS1 affects proliferation and apoptosis of cervical cancer cells by promoting FRRS1 expression via transcription factor ELF1
Huan Liu, Li Liu, Qiong Liu et al. (5 authors)
Cell Cycle
Open Access
Published: Jan 2022
15 citations
15 citations
131 days before retraction
Applications of noncoding RNAs in brain cancer patients
Małgorzata Grabowska, Julia O. Misiorek, Żaneta Zarębska et al. (4 authors)
Elsevier eBooks
Published: Jan 2022
1 citation
1 citation
135 days before retraction
Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance
Huimin Lv, Shanshan Jin, Binbin Zou et al. (6 authors)
Cancer Cell International
Open Access
Published: Oct 2021
9 citations
9 citations
216 days before retraction
The regulatory role of antisense lncRNAs in cancer
Biao Liu, Wei Xiang, Jiahao Liu et al. (10 authors)
Cancer Cell International
Open Access
Published: Aug 2021
50 citations
50 citations
259 days before retraction
Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA
Tandrima Mitra, Selvakumar Elangovan
Molecular and Cellular Biochemistry
Published: Aug 2021
29 citations
29 citations
261 days before retraction
HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
Yujie Dong, Wei Feng, Li Yan
Frontiers in Cell and Developmental Biology
Open Access
Published: Jul 2021
19 citations
19 citations
308 days before retraction
Role of noncoding RNA in drug resistance of prostate cancer
Lifeng Ding, Ruyue Wang, Danyang Shen et al. (10 authors)
Cell Death and Disease
Open Access
Published: Jun 2021
53 citations
53 citations
342 days before retraction
Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview
César López‐Camarillo, Érika Ruiz-García, Yarely M. Salinas-Vera et al. (7 authors)
Cells
Open Access
Published: Jun 2021
7 citations
7 citations
344 days before retraction
miR‑130a‑3p promotes cell proliferation and invasion by targeting estrogen receptor α and androgen receptor in cervical cancer
Qiong Fan, Ting Huang, Xiao Sun et al. (10 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Feb 2021
19 citations
19 citations
445 days before retraction
LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin
Mohammad Taheri, Hamed Shoorei, Farhad Tondro Anamag et al. (5 authors)
Experimental and Molecular Pathology
Published: Jan 2021
40 citations
40 citations
491 days before retraction
Roles of the HOX Proteins in Cancer Invasion and Metastasis
Ana Paço, Simone Aparecida de Bessa Garcia, Joana Leitão-Castro et al. (5 authors)
Cancers
Open Access
Published: Dec 2020
48 citations
48 citations
510 days before retraction
Roles and Mechanisms of the Long Noncoding RNAs in Cervical Cancer
Miguel Ángel Cáceres-Durán, Ândrea Ribeiro‐dos‐Santos, Amanda Vidal
International Journal of Molecular Sciences
Open Access
Published: Dec 2020
43 citations
43 citations
511 days before retraction
Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies
Subhasree Kumar, Edward A. Gonzalez, Pranela Rameshwar et al. (4 authors)
Cancers
Open Access
Published: Dec 2020
95 citations
95 citations
527 days before retraction
MiR-130a-3p blocks Wnt signaling cascade in the triple-negative breast cancer by targeting the key players at multiple points
Jafar Poodineh, Majid Sirati‐Sabet, Masoumeh Rajabibazl et al. (4 authors)
Heliyon
Open Access
Published: Nov 2020
26 citations
26 citations
561 days before retraction
Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects
Maria Luiza Tabosa de Carvalho Galvão, Eliane Campos Coimbra
Critical Reviews in Oncology/Hematology
Published: Sep 2020
20 citations
20 citations
601 days before retraction
Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
Xin Wen, Shui Liu, Jiyao Sheng et al. (4 authors)
PeerJ
Open Access
Published: May 2020
17 citations
17 citations
717 days before retraction
Long non-coding RNA in cervical cancer: From biology to therapeutic opportunity
Jiaxing He, Bingyu Huang, Kun Zhang et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: May 2020
85 citations
85 citations
726 days before retraction
<p>LncRNA miR503HG Regulates the Drug Resistance of Recurrent Cervical Squamous Cell Carcinoma Cells by Regulating miR-155/Caspase-3</p>
Shanshan Zhao, Mingxin Yu, Lei Wang
Cancer Management and Research
Open Access
Published: Mar 2020
10 citations
10 citations
806 days before retraction
RETRACTED: HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2
Yafei Ye, Shengnan Yang, Yanping Han et al. (7 authors)
Open Biology
Open Access
Published: Sep 2019
41 citations
41 citations
988 days before retraction
PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis
Yinmou Guo, Peiru Yue, Yumei Wang et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jul 2019
44 citations
44 citations
1026 days before retraction
LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells
Mi Zhang, Siyu Liu, Chenyang Fu et al. (13 authors)
Cancer Biotherapy and Radiopharmaceuticals
Open Access
Published: Mar 2019
19 citations
19 citations
1153 days before retraction
Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
Minhui Yang, Li Zhao, Lan Wang et al. (12 authors)
Molecular Cancer
Open Access
Published: Mar 2019
85 citations
85 citations
1172 days before retraction
Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204
Hui Zhou, Yabin Ma, Dequan Zhong et al. (4 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Feb 2019
26 citations
26 citations
1181 days before retraction
Long Non-coding RNA DLEU1 Promotes Proliferation and Invasion by Interacting With miR-381 and Enhancing HOXA13 Expression in Cervical Cancer
Chang Liu, Xing Tian, Jing Zhang et al. (4 authors)
Frontiers in Genetics
Open Access
Published: Dec 2018
47 citations
47 citations
1256 days before retraction
Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review
Fuhong Zhang, Xiaowan Chen, Kehu Xi et al. (9 authors)
OncoTargets and Therapy
Open Access
Published: Nov 2018
6 citations
6 citations
1292 days before retraction
Long non-coding RNA HOXD-AS1 in cancer
Lianlian Li, Yong Wang, Xiaoyu Zhang et al. (7 authors)
Clinica Chimica Acta
Published: Oct 2018
46 citations
46 citations
1322 days before retraction
Long noncoding RNA SNHG12 facilitates the tumorigenesis of glioma through miR-101-3p/FOXP1 axis
Yuchen Sun, Jian Liu, Liangzhao Chu et al. (7 authors)
Gene
Published: Aug 2018
38 citations
38 citations
1377 days before retraction
Quick Stats
Total Citations:
32
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025